Boston, MA, United States of America

Sandra Abbott

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 10.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

8 patents (USPTO):

Title: The Innovative Journey of Sandra Abbott

Introduction

Sandra Abbott, a distinguished inventor based in Boston, MA, has made significant contributions to the field of biopharmaceuticals. With a total of eight patents to her name, she is recognized for her groundbreaking work in developing monoclonal antibodies that target critical biological pathways involved in various diseases.

Latest Patents

Among her latest patents, Sandra has developed the Anti-notch3 antibodies, which are designed to bind and inhibit the activation of human Notch3. This innovative approach offers potential treatment options for cell proliferative diseases and disorders, including certain forms of cancer associated with the activation of Notch3. Additionally, she holds a patent for Anti-GDF-15 antibodies, which inhibit the activity of human GDF15, providing a novel therapeutic avenue for addressing body weight loss, including cachexia, linked to the over-expression of GDF15.

Career Highlights

Currently, Sandra Abbott is employed at Aveo Pharmaceuticals, Inc., where she continues to advance her research and drive innovation. Her expertise in antibody development has positioned her as a key player in the biopharmaceutical industry, contributing to the creation of therapies that address critical health challenges.

Collaborations

Throughout her career, Sandra has collaborated with esteemed colleagues, including William M Winston, Jr. and Jeno Gyuris. These collaborations not only enhance her research capabilities but also foster a dynamic exchange of ideas within the scientific community.

Conclusion

Sandra Abbott's pioneering work and innovative spirit exemplify the vital role inventors play in transforming scientific discovery into therapeutic advancements. With her impressive portfolio of patents and her commitment to improving health outcomes, she continues to inspire future generations of inventors in the biopharmaceutical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…